These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 19047290)

  • 21. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee.
    Ambros PF; Ambros IM; Brodeur GM; Haber M; Khan J; Nakagawara A; Schleiermacher G; Speleman F; Spitz R; London WB; Cohn SL; Pearson AD; Maris JM
    Br J Cancer; 2009 May; 100(9):1471-82. PubMed ID: 19401703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Important Role of the Radiologist in Determining the Indications for the Surgical Treatment of Neuroblastoma with Vascular Image-Defined Risk Factors: A Case Report.
    Sosnowska-Sienkiewicz P; Mańkowski P; Wojas A; Jończyk-Potoczna K; Januszkiewicz-Lewandowska D
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33802932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Practical Application of the International Neuroblastoma Risk Group Staging System: A Pictorial Review.
    Del Campo Braojos F; Donnelly LF
    Curr Probl Diagn Radiol; 2019; 48(5):509-518. PubMed ID: 30268582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New international staging system and classification of risk groups in neuroblastoma].
    Balwierz W; Wieczorek A
    Przegl Lek; 2010; 67(6):345-9. PubMed ID: 21344759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project.
    Sokol E; Desai AV; Applebaum MA; Valteau-Couanet D; Park JR; Pearson ADJ; Schleiermacher G; Irwin MS; Hogarty M; Naranjo A; Volchenboum S; Cohn SL; London WB
    J Clin Oncol; 2020 Jun; 38(17):1906-1918. PubMed ID: 32315273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A non-inferiority study of MRI versus CT for staging and image-defined risk factor assessment in the preoperative work-up of abdominopelvic neuroblastoma.
    Delval A; Touitou T; Gondry-Jouet C; Khanfar C; Haraux E
    Eur J Radiol; 2024 Aug; 177():111580. PubMed ID: 38905801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and biological features prognostic of survival after relapse or progression of INRGSS stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
    Campbell K; Kao PC; Naranjo A; Kamijo T; Ramanujachar R; London WB; DuBois SG
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30054. PubMed ID: 36316811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent?
    Iehara T; Hiyama E; Tajiri T; Yoneda A; Hamazaki M; Fukuzawa M; Hosoi H; Sugimoto T; Sawada T
    Eur J Cancer; 2012 Jul; 48(11):1707-12. PubMed ID: 22305511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.
    Fumino S; Kimura K; Iehara T; Nishimura M; Nakamura S; Souzaki R; Nishie A; Taguchi T; Hosoi H; Tajiri T
    J Pediatr Surg; 2015 Dec; 50(12):2102-6. PubMed ID: 26388125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete surgical resection improves outcome in INRG high-risk patients with localized neuroblastoma older than 18 months.
    Fischer J; Pohl A; Volland R; Hero B; Dübbers M; Cernaianu G; Berthold F; von Schweinitz D; Simon T
    BMC Cancer; 2017 Aug; 17(1):520. PubMed ID: 28778185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
    Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
    Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
    Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
    J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?
    Lucas JT; McCarville MB; Cooper DA; Doubrovin M; Wakefield D; Santiago T; Li Y; Li X; Krasin M; Santana V; Furman W; Davidoff AM
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):869-877. PubMed ID: 30496881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroblastoma: validation of the INRG classification system in a small series.
    Ramos Elbal E; Galera Miñarro AM; Llinares Riestra ME; Bermúdez Cortés M; Fuster Soler JL
    Clin Transl Oncol; 2019 Dec; 21(12):1776-1780. PubMed ID: 30949929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of image-defined risk factors, tumor resectability, and prognosis in children with localized neuroblastoma.
    Zhang AA; Pan C; Xu M; Wang XX; Ye QD; Gao YJ; Tang JY
    World J Pediatr; 2019 Dec; 15(6):572-579. PubMed ID: 31342464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can neoadjuvant chemotherapy reduce the surgical risks for localized neuroblastoma patients with image-defined risk factors at the time of diagnosis?
    Yoneda A; Nishikawa M; Uehara S; Oue T; Usui N; Inoue M; Fukuzawa M; Okuyama H
    Pediatr Surg Int; 2016 Mar; 32(3):209-14. PubMed ID: 26763000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of MYCN amplification in international neuroblastoma staging system stage 1 and 2 neuroblastoma: a report from the International Neuroblastoma Risk Group database.
    Bagatell R; Beck-Popovic M; London WB; Zhang Y; Pearson AD; Matthay KK; Monclair T; Ambros PF; Cohn SL;
    J Clin Oncol; 2009 Jan; 27(3):365-70. PubMed ID: 19047282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management in pediatric neuroblastoma diagnosis and treatment: a 20-year, single-center experience.
    Spencer B; Patel A; Cilley R; Grant CN
    World J Pediatr; 2022 Feb; 18(2):120-125. PubMed ID: 34854024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
    Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Ladanyi M; Gerald WL
    J Clin Oncol; 1996 Jul; 14(7):2174-80. PubMed ID: 8683252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.